It is a service private limited company based in Thane, Maharashtra, India, established in 2019.
2019 | Thane, Maharashtra, India | ActiveGalilcon Pharmaceuticals Private Limited, a active private limited company, was established on 20 February 2019 in Thane, Maharashtra, India. Engaging in other services within the service sector, it holds CIN: U93000MH2019PTC321545. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹50.00 K .
It upholds a compliant status. Its leadership includes Vinay Choudhary (Director), Shakun Choudhary (Director), Jay Kumar Choudhary (Director). Past directors included Vinay Choudhary. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Flat No.202 Plot No.177 Sector 31Ges Vashi Village, Thane, Maharashtra, 400705.
U93000MH2019PTC321545
321545
20 February 2019
₹0.50 M
₹50.00 K
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Galilcon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vinay Choudhary | Director | 25 May 2021 | Current |
| Shakun Choudhary | Director | 28 Mar 2023 | Current |
| Jay Kumar Choudhary | Director | 20 Feb 2019 | Current |
| John Lenard Godfrey | Director | 20 Feb 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Galilcon Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 18% decrease in profit. The company's net worth observed a substantial decline by a decrease of 249.72%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Galilcon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Galilcon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Galilcon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Galilcon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Galilcon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
The activity Galilcon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was completed.
Progress on Shakun Choudhary was appointed as a Director was appointed as a Director on 28 Mar 2023 & has been associated with this company since 2 years 8 months . was documented.
Vinay Choudhary was appointed as a Director was appointed as a Director on 25 May 2021 & has been associated with this company since 4 years 7 months . was recorded as a recent event.
Jay Kumar Choudhary was appointed as a Director was appointed as a Director on 20 Feb 2019 & has been associated with this company since 6 years 10 months . was recorded as a recent event.
John Lenard Godfrey was appointed as a Director was appointed as a Director on 20 Feb 2019 & has been associated with this company since 6 years 10 months . was recorded as a recent event.
The CIN of Galilcon Pharmaceuticals Private Limited is U93000MH2019PTC321545.
Galilcon Pharmaceuticals Private Limited is headquartered at Flat No.202 Plot No.177 Sector 31Ges Vashi Village, Thane, Maharashtra, 400705.
Galilcon Pharmaceuticals Private Limited was incorporated on 20 February 2019.
The current directors of Galilcon Pharmaceuticals Private Limited are
The primary industry of Galilcon Pharmaceuticals Private Limited is Service.
Galilcon Pharmaceuticals Private Limited is unlisted.
The authorized capital of Galilcon Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹50.00 K .
The compliance status of Galilcon Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX